Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma

Cancer Genetics and Cytogenetics

Volumn 203, Issue 2, 2010, Pages 345-347

  Jimenez Sousa, Maria Angeles ^a   Ferro, Maria Teresa ^a   Talavera, Maria ^a   Villalon, Concepcion ^a   Cabello, Pablo ^a   Laraña, Jose ^a   Herrera, Pilar ^a   Garcia Sagredo, Jose Miguel ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CD38 ANTIGEN; CD56 ANTIGEN; DEXAMETHASONE; HEMOGLOBIN; MELPHALAN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; ZOLEDRONIC ACID;

AGED; BONE INJURY; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME 5P; CHROMOSOME DELETION; CYTOGENETICS; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LETTER; LYMPHOCYTIC INFILTRATION; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PLASMACYTOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TRISOMY 8;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETICS; FEMALE; HUMANS; KARYOTYPING; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; TRISOMY;

EID: 78650027207     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.09.010     Document Type: Letter

References (23)

1. Munshi N.C. Investigative tools for diagnosis and management. Hematology Am Soc Hematol Educ Program 2008, 298-305.
2. Palumbo A., Gay F. How to treat elderly patients with multiple myeloma: combination of therapy or sequencing. Hematology Am Soc Hematol Educ Program 2009, 566-577.
3. Ishii Y., Hsiao H.H., Sashida G., Ito Y., Miyazawa K., Kodama A., et al. Derivative (1;7)(q10;p10) in multiple myeloma: a sign of therapy-related hidden myelodysplastic syndrome. Cancer Genet Cytogenet 2006, 167:131-137.
4. Fadl-Elmula I. Chromosomal changes in uroepithelial carcinomas. Cell Chromosome 2005, 4:1.
5. Jancarkova N., Krkavcova M., Janashia M., Freitag P., Duskova J., Cibula D. Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors. Ceska Gynekol 2008, 73:79-86. [In Czech].
6. Manor E., Tetro S., Bodner L. Translocation (12;14) and other chromosome abnormalities in squamous cell carcinoma of the tongue. Eur Arch Otorhinolaryngol 2010, 267:1273-1276.
7. Mertens F., Johansson B., Mitelman F. Isochromosomes in neoplasia. Genes Chromosomes Cancer 1994, 10:221-230.
8. Vanni R., Scarpa R.M. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 1986, 46:4873.
9. Welborn J., Jenks H., Taplett J., Walling P. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations. Cancer Genet Cytogenet 2004, 155:33-41.
10. Pedersen-Bjergaard J., Daugaard G., Hansen S.W., Philip P., Larsen S.O., Rørth M. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991, 338:359-363.
11. Pedersen-Bjergaard J., Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia?. Cancer Genet Cytogenet 1991, 55:119-124.
12. Pedersen-Bjergaard J., Philip P., Larsen S.O., Jensen G., Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990, 76:1083-1091.
13. Christodoulou J., Schoch C., Schnittger S., Haferlach T. Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT). Ann Hematol 2004, 83:386-389.
14. Tamura S., Kanamaru A. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM). Leuk Lymphoma 1995, 16(3-4):263-270.
15. El-Rifai W., Elonen E., Larramendy M., Ruutu T., Knuutila S. Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia 1997, 11:958-963.
16. Schoch C., Bursch S., Kern W., Schnittger S., Hiddemann W., Haferlach T. Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemia. Cancer Genet Cytogenet 2001, 127:85-88.
17. Schmidt H.H., Strehl S., Thaler D., Strunk D., Sill H., Linkesch W., et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004, 18:1115-1121.
18. Panani A.D. Gain of an isochromosome 5p: a rare recurrent abnormality in acute myeloid leukemia. Vivo 2006, 20:359-360.
19. Herry A., Douet-Guilbert N., Morel F., Le Bris M.J., De Braekeleer M. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML. Eur J Haematol 2007, 78:457-467.
20. Lessard M., Hélias C., Struski S., Perrusson N., Uettwiller F., Mozziconacci M.J., et al. Groupe Francophone de Cytogénétique Hématologique. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?. Cancer Genet Cytogenet 2007, 176:1-21.
21. Rödjer S., Swolin B., Weinfeld A., Westin J. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma. Cancer Genet Cytogenet 1990, 48:67-73.
22. Amiel A., Yukla M., Yogev S., Manor Y., Fejgin M.D., Lishner M. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma. Cancer Genet Cytogenet 2004, 152:84-87.
23. Amiel A., Fridman K., Elis A., Gaber E., Manor Y., Fejgin M., et al. Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma. Cancer Genet Cytogenet 1999, 113:45-48.